1. Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial (AGO-GYN5). Issue 2 (1st February 2014) Authors: Emons, Günter; Gorchev, Grigor; Harter, Philipp; Wimberger, Pauline; Stähle, Anne; Hanker, Lars; Hilpert, Felix; Beckmann, Matthias W.; Dall, Peter; Gründker, Carsten; Sindermann, Herbert; Sehouli, Jalid Journal: International journal of gynecological cancer Issue: Volume 24:Issue 2(2014) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗